CTSO

CTSO

Cytosorbents Corporation Common Stock

$1.090+-0.000 (-0.000%)

Echtzeitkurs

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.090

Hoch

$1.090

Tief

$1.090

Volumen

0.01M

Unternehmensfundamentaldaten

Handelsstatistiken

Ähnliche Nachrichten

PR Newswire

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

Mehr anzeigen
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
Analyst Upgrades

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.

Mehr anzeigen
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents with a Neutral and maintains $1 price target.

Mehr anzeigen
HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target
PR Newswire

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

Mehr anzeigen
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
Analyst Upgrades

D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.

Mehr anzeigen
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target